Neem leaf extract induces cell death by apoptosis and autophagy in B-chronic lymphocytic leukemia cells

References

• Dores GM, Anderson WF, Curtis RE, et al. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 2007;139:809–819.
   PubMed Web of Science ®Google Scholar
• Wierda WG, Chiorazzi N, Dearden C, et al. Chronic lymphocytic leukemia: new concepts for future therapy. Clin Lymphoma Myeloma Leuk 2010;10:369–378.
   PubMed Web of Science ®Google Scholar
• Hallek M, Pflug N. Chronic lymphocytic leukemia. Ann Oncol 2010;21(Suppl. 7):vii154–vii164.
   Google Scholar
• Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841–894.
   PubMed Web of Science ®Google Scholar
• Abbott BL. Chronic lymphocytic leukemia: recent advances in diagnosis and treatment. Oncologist 2006;11:21–30.
   PubMed Web of Science ®Google Scholar
• Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD. Predicting clinical outcome in CLL: how and why. Hematology Am Soc Hematol Educ Program 2009:421–429.
   Google Scholar
• Keating MJ, O’Brien S, Albitar M, et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol 2005;23:4079–4088.
   PubMed Web of Science ®Google Scholar
• Byrd JC, Peterson BL, Morrison VA, et al. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood 2003;101:6–14.
   PubMed Web of Science ®Google Scholar
• Hallek M, Fingerle-Rowson G, Fink A-M, et al. First-line treatment with fludarabine (F), cyclophosphamide (C), and rituximab (R) (FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic leukemia (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL Study Group. Blood 2009;114(Suppl. 1): Abstract 535.
   Web of Science ®Google Scholar
• Hillmen P, Skotnicki AB, Robak T, et al. Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia. J Clin Oncol 2007;25:5616–5623.
   PubMed Web of Science ®Google Scholar
• Knauf WU, Lissichkov T, Aldaoud A, et al. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol 2009;27:4378–4384.
   PubMed Web of Science ®Google Scholar
• Roman V, Billard C, Kern C, et al. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol 2002;117:842–851.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Call TG, Zent CS, et al. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol 2009;27:3808–3814.
   PubMed Web of Science ®Google Scholar
• Balakrishnan K, Wierda WG, Keating MJ, et al. Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells. Blood 2008;112:1971–1980.
   PubMed Web of Science ®Google Scholar
• Brahmachari G. Neem--an omnipotent plant: a retrospection. Chembiochem 2004;5:408–421.
   PubMed Web of Science ®Google Scholar
• Priyadarsini RV, Murugan RS, Sripriya P, et al. The neem limonoids azadirachtin and nimbolide induce cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells. Free Radic Res 2010;44:624–634.
   PubMed Web of Science ®Google Scholar
• Manikandan P, Anandan R, Nagini S. Evaluation of Azadirachta indica leaf fractions for in vitro antioxidant potential and protective effects against H2O2-induced oxidative damage to pBR322 DNA and red blood cells. J Agric Food Chem 2009;57:6990–6996.
   PubMed Web of Science ®Google Scholar
• Harish Kumar G, Vidya Priyadarsini R, Vinothini G, et al. The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis. Invest New Drugs 2010;28:392–401.
   PubMed Web of Science ®Google Scholar
• Priyadarsini RV, Manikandan P, Kumar GH, et al. The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis. Free Radic Res 2009;43:492–504.
   PubMed Web of Science ®Google Scholar
• Harish Kumar G, Chandra Mohan KV, Jagannadha Rao A, et al. Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells. Invest New Drugs 2009;27:246–252.
   PubMed Web of Science ®Google Scholar
• Roy MK, Kobori M, Takenaka M, et al. Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica). Phytother Res 2007;21:245–250.
   PubMed Web of Science ®Google Scholar
• Vinothini G, Manikandan P, Anandan R, et al. Chemoprevention of rat mammary carcinogenesis by Azadirachta indica leaf fractions: modulation of hormone status, xenobiotic-metabolizing enzymes, oxidative stress, cell proliferation and apoptosis. Food Chem Toxicol 2009;47:1852–1863.
   Google Scholar
• Mandal-Ghosh I, Chattopadhyay U, Baral R. Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen. Cancer Immun 2007;7:8.
   PubMedGoogle Scholar
• Subapriya R, Kumaraguruparan R, Nagini S. Expression of PCNA, cytokeratin, Bcl-2 and p53 during chemoprevention of hamster buccal pouch carcinogenesis by ethanolic neem (Azadirachta indica) leaf extract. Clin Biochem 2006;39:1080–1087.
   PubMed Web of Science ®Google Scholar
• Chanan-Khan A. Bcl-2 antisense therapy in B-cell malignancies. Blood Rev 2005;19:213–221.
   PubMed Web of Science ®Google Scholar
• Moreira JN, Santos A, Simoes S. Bcl-2-targeted antisense therapy (Oblimersen sodium): towards clinical reality. Rev Recent Clin Trials 2006;1:217–235.
   Google Scholar
• Chandra J, Tracy J, Loegering D, et al. Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance. Blood 2006;107:2501–2506.
   PubMed Web of Science ®Google Scholar
• Patel MP, Masood A, Patel PS, et al. Targeting the Bcl-2. Curr Opin Oncol 2009;21:516–523.
   PubMed Web of Science ®Google Scholar
• Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009;15:1126–1132.
   PubMed Web of Science ®Google Scholar
• Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008;4:600–606.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007;87:99–163.
   PubMed Web of Science ®Google Scholar
• Sithisarn P, Supabphol R, Gritsanapan W. Antioxidant activity of Siamese neem tree (VP1209). J Ethnopharmacol 2005;99:109–112.
   PubMed Web of Science ®Google Scholar
• Subapriya R, Nagini S. Medicinal properties of neem leaves: a review. Curr Med Chem Anticancer Agents 2005;5:149–146.
   PubMedGoogle Scholar
• Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol 2010;221:3–12.
   PubMed Web of Science ®Google Scholar
• Noda T, Fujita N, Yoshimori T. The late stages of autophagy: how does the end begin?Cell Death Differ 2009;16:984–990.
   PubMed Web of Science ®Google Scholar
• Tasdemir E, Maiuri MC, Galluzzi L, et al. Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 2008;10:676–687.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Prasad S, Reuter S, et al. Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. J Biol Chem 2010;285:35406–35417.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Reuter S, Phromnoi K, et al. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax. J Biol Chem 2011;286:1134–1146.
   PubMed Web of Science ®Google Scholar
• Yu SW, Wang Y, Frydenlund DS, et al. Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release. ASN Neuro 2009;1(5). pii: e00021.
   Web of Science ®Google Scholar
• Chung S, Yao H, Caito S, et al. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 2010;501: 79–90.
   PubMed Web of Science ®Google Scholar
• Jia YL, Li J, Qin ZH, et al. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 2009;11:918–928.
   PubMed Web of Science ®Google Scholar
• Li J, Qin Z, Liang Z. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in human U251 glioma cells. BMC Cancer 2009;9:215.
   PubMed Web of Science ®Google Scholar
• Sinha S, Colbert CL, Becker N, et al. Molecular basis of the regulation of Beclin 1-dependent autophagy by the gamma-herpesvirus 68 Bcl-2 homolog M11. Autophagy 2008;4:989–997.
   PubMed Web of Science ®Google Scholar
• Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030–9040.
   PubMed Web of Science ®Google Scholar
• Maiuri MC, Galluzzi L, Morselli E, et al. Autophagy regulation by p53. Curr Opin Cell Biol 2010;22:181–185.
   PubMed Web of Science ®Google Scholar
• Eisenberg-Lerner A, Bialik S, Simon HU, et al. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009;16:966–975.
   PubMed Web of Science ®Google Scholar